Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin:: A dose-response study

被引:78
作者
Burns, FJ [1 ]
Uddin, AN [1 ]
Wu, F [1 ]
Nádas, A [1 ]
Rossman, TG [1 ]
机构
[1] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA
关键词
arsenic; arsenite; cancer; hairless; mouse; radiation; skin; ultraviolet; UV;
D O I
10.1289/ehp.6655
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The present study was designed to establish the form of the dose-response relationship for dietary sodium arsenite as a co-carcinogen with ultraviolet radiation (UVR) in a mouse skin model. Hairless mice (strain Skh1) were fed sodium arsenite continuously in drinking water starting at 21 days of age at concentrations of 0.0, 1.25, 2.5, 5.0, and 10 mg/L. At 42 days of age, solar spectrum UVR exposures were applied three times weekly to the dorsal skin at 1.0 kJ/m(2) per exposure until the experiment ended at 182 days. Untreated mice and mice fed only arsenite developed no tumors. In the remaining groups a total of 322 locally invasive squamous carcinomas occurred. The carcinoma yield in mice exposed only to UVR was 2.4 +/- 0.5 cancers/mouse at 182 days. Dietary arsenite markedly. enhanced the UVR-induced cancer yield in a pattern consistent with linearity up to a peak of 11.1 +/- 1.0 cancers/mouse at 5.0 mg/L arsenite, representing a peak enhancement ratio of 4.63 +/- 1.05. A decline occurred to 6.8 +/- 0.8 cancers/mouse at 10.0 mg/L arsenite. New cancer rates exhibited a consistent-with-linear dependence on time beginning after initial cancer-free intervals ranging between 88 and 95 days. Epidermal hyperplasia was elevated by arsenite alone and UVR alone and was greater than additive for the combined exposures as were growth rates of the cancers. These results demonstrate the usefulness of a new animal model for studying the carcinogenic action of dietary arsenite on skin exposed to UVR and should contribute to understanding how to make use of animal data for assessment of human cancer risks in tissues exposed to mixtures of carcinogens and cancer-enhancing agents.
引用
收藏
页码:599 / 603
页数:5
相关论文
共 40 条
  • [11] Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors
    Germolec, DR
    Spalding, J
    Yu, HS
    Chen, GS
    Simeonova, PP
    Humble, MC
    Bruccoleri, A
    Boorman, GA
    Foley, JF
    Yoshida, T
    Luster, MI
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (06) : 1775 - 1785
  • [12] Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors
    Germolec, DR
    Spalding, J
    Boorman, GA
    Wilmer, JL
    Yoshida, T
    Simeonova, PP
    Bruccoleri, A
    Kayama, F
    Gaido, K
    Tennant, R
    Burleson, F
    Dong, WM
    Lang, RW
    Luster, MI
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 1997, 386 (03) : 209 - 218
  • [13] Interference by toxic metal ions with DNA repair processes and cell cycle control:: Molecular mechanisms
    Hartwig, A
    Asmuss, M
    Ehleben, I
    Herzer, U
    Kostelac, D
    Pelzer, A
    Schwerdtle, T
    Bürkle, A
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 : 797 - 799
  • [14] Mutagenicity of arsenic in mammalian cells: Role of reactive oxygen species
    Hei, TK
    Liu, SX
    Waldren, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8103 - 8107
  • [15] Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes
    Hu, Y
    Su, L
    Snow, ET
    [J]. MUTATION RESEARCH-DNA REPAIR, 1998, 408 (03): : 203 - 218
  • [16] Arsenic-induced NFκβ transactivation through Erks- and JNKs-dependent pathways in mouse epidermal JB6 cells
    Huang, CS
    Li, JX
    Ding, M
    Wang, LY
    Shi, XL
    Castranova, V
    Vallyathan, V
    Ju, G
    Costa, M
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2001, 222 (1-2) : 29 - 34
  • [17] Arsenic carcinogenicity testing
    Huff, J
    Chan, P
    Waalkes, M
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 (04) : A170 - A170
  • [18] CYCLINS AND CANCER .2. CYCLIN-D AND CDK INHIBITORS COME OF AGE
    HUNTER, T
    PINES, J
    [J]. CELL, 1994, 79 (04) : 573 - 582
  • [19] CELL-CYCLE CHECKPOINTS AND DNA-REPAIR PRESERVE THE STABILITY OF THE HUMAN GENOME
    KAUFMANN, WK
    [J]. CANCER AND METASTASIS REVIEWS, 1995, 14 (01) : 31 - 41
  • [20] LI J-H, 1989, Molecular Toxicology, V2, P1